TY - JOUR
T1 - Bacterial Adhesins and Host Factors
T2 - Role in the Development and Outcome of Escherichia coli Bacteremia
AU - Maslow, Joel N.
AU - Mulligan, Maury Ellis
AU - Adams, Kenneth S.
AU - Justis, Janice C.
AU - Arbeit, Robert D.
N1 - Funding Information:
Received 5 October 1992; revised 7 January 1993. Financial support: J. N. M. and R. D. A. are supported by the Medical Research Program, Department of Veterans Affairs. Reprints or correspondence: Dr. Joel N. Maslow, Research Service (151), VA Medical Center, 150 South Huntington Avenue, Boston, Massachusetts 02130.
PY - 1993/7/1
Y1 - 1993/7/1
N2 - To assess the contributions of bacterial virulence factors and defects in host defense to Escherichia coli bacteremia, we examined isolates and available medical records from 169 episodes at two hospitals. Adhesins and hemolysin virulence factors were documented in 84% of bacteremia-associated isolates originating from the urinary and respiratory tracts and in 50% of such isolates originating from other extraurinary foci. Of the evaluable episodes of bacteremia involving 35 adhesin-negative isolates, 21 (60%) were in patients who had mucocutaneous defects at the primary site of infection, and another 13 (37%) were in patients who had comorbid systemic diseases (i.e., chronic renal failure or alcoholism) associated with impaired leukocyte function. In contrast, of 93 evaluable episodes with adhesin-positive isolates, 22 (24%) were in patients who had none of these host conditions (P =.008). Overall, of evaluable episodes of bacteremia involving 128 isolates, 71 (55%) had both bacterial virulence-associated and host-related risk factors. Mortality was related to the severity of comorbid illnesses and was not affected by the presence of the bacterial virulence factors assessed.
AB - To assess the contributions of bacterial virulence factors and defects in host defense to Escherichia coli bacteremia, we examined isolates and available medical records from 169 episodes at two hospitals. Adhesins and hemolysin virulence factors were documented in 84% of bacteremia-associated isolates originating from the urinary and respiratory tracts and in 50% of such isolates originating from other extraurinary foci. Of the evaluable episodes of bacteremia involving 35 adhesin-negative isolates, 21 (60%) were in patients who had mucocutaneous defects at the primary site of infection, and another 13 (37%) were in patients who had comorbid systemic diseases (i.e., chronic renal failure or alcoholism) associated with impaired leukocyte function. In contrast, of 93 evaluable episodes with adhesin-positive isolates, 22 (24%) were in patients who had none of these host conditions (P =.008). Overall, of evaluable episodes of bacteremia involving 128 isolates, 71 (55%) had both bacterial virulence-associated and host-related risk factors. Mortality was related to the severity of comorbid illnesses and was not affected by the presence of the bacterial virulence factors assessed.
UR - http://www.scopus.com/inward/record.url?scp=0027256041&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027256041&partnerID=8YFLogxK
U2 - 10.1093/clinids/17.1.89
DO - 10.1093/clinids/17.1.89
M3 - Article
C2 - 8102557
AN - SCOPUS:0027256041
SN - 1058-4838
VL - 17
SP - 89
EP - 97
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 1
ER -